• 1
    Macfarlane A, Mugford M. Birth Counts: Statistics of Pregnancy and Childbirth, 2nd edition. London : The Stationery Office, 2000.
  • 2
    Organisation for Economic Co-operation and Development. OECD Health Data 2001: A Comparative Analysis of 29 Countries. Paris : OECD, 2001.
  • 3
    Hack M, Fanaroff AA. Outcomes of children of extremely low birthweight and gestational age in the 1990s. Early Hum Dev 1999;53: 193218.
  • 4
    Finkler SA. The distinction between costs and charges. Ann Intern Med 1982;96: 102109.
  • 5
    Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Healthcare 1989;5: 559575.
  • 6
    Mehrez A, Gafni A. Quality-adjusted life years, utility theory, and healthy-years equivalents. Med Decis Making 1989;9: 142149.
  • 7
    Nord E. An alternative to QALYs: the saved young life equivalent (SAVE). Br Med J 1992;305: 875877.
  • 8
    Phibbs CS, Williams RL, Phibbs RH. Newborn risk factors and costs of neonatal intensive care. Pediatrics 1981;68: 313321.
  • 9
    Doyle LW, Murton LJ, Kitchen WH. Increasing the survival of extremely immature (24 to 28-weeks gestation) infants—at what cost?. Med J Aust 1989;150: 558568.
  • 10
    Mugford M. The cost of neonatal care: reviewing the evidence. Soc Präventivmed 1995;40: 361368.
  • 11
    Petrou S, Davidson LL. Economic issues in the follow-up of neonates. Semin Neonatol 2000;5: 159169.
  • 12
    Hallam L, Rudbeck B, Bradley M. Resource use and costs of caring for oxygen-dependent children: a comparison of hospital and home-based care. J Neonatal Nurs 1996;2: 2530.
  • 13
    McLoughlin A, Hillier VF, Robinson MJ. Parental costs of neonatal visiting. Arch Dis Child 1993;68: 597599.
  • 14
    Gennaro S. Leave and employment in families of preterm low birthweight infants. Image J Nurs Sch 1996;28: 193198.
  • 15
    Brooten D, Kumar S, Brown LP, et al. A randomized clinical trial of early hospital discharge and home follow-up of very-low-birth-weight infants. New Engl J Med 1986;315: 934939.
  • 16
    McCormick MC, Bernbaum JC, Eisenberg JM, Kustra S, Finnegan E. Costs incurred by parents of very low birth weight infants after the initial neonatal hospitalization. Pediatrics 1991;88: 533541.
  • 17
    Rogowski J. Cost-effectiveness of care for very low birth weight infants. Pediatrics 1998;102: 3543.
  • 18
    Stevenson RC, McCabe CJ, Pharoah PO, Cooke RWI. Cost of care for a geographically determined population of low birthweight infants to age 8–9 years. I. Children without disability. Arch Dis Child Fetal Neonatal Ed 1996;74: F114F117.
  • 19
    Chaikind S, Corman H. The impact of low birthweight on special education costs. J Health Econ 1991;10: 291311.
  • 20
    Ladden M. The impact of preterm birth on the family and society: transition to home part 2. Pediatr Nurs 1990;16: 620622.
  • 21
    Papiernik E, Keith LG. The cost effectiveness of preventing preterm delivery in twin pregnancies. Acta Geneticae Medicae et Gemellologiae Roma 1990;39: 361369.
  • 22
    Javitt J, Dei Cas R, Chiang YP. Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity. Pediatrics 1993;91: 859866.
  • 23
    Boyle MH, Torrance GW, Sinclair JC, Horwood SP. Economic evaluation of neonatal intensive care of very-low-birthweight infants. N Engl J Med 1983;308: 13301337.
  • 24
    Walker DB, Feldman A, Vohr BR, Oh W. Cost-benefit analysis of neonatal intensive care for infants weighing less than 1000 grams at birth. Pediatrics 1984;74: 2024.
  • 25
    Walker DB, Vohr BR, Oh W. Economic analysis of regionalized neonatal care for very low-birth-weight infants in the state of Rhode Island. Pediatrics 1985;76: 6974.
  • 26
    Kitchen WH, Bowman E, Callanan C, Campbell NT, Carse EA, Charlton M. The cost of improving the outcome for infants of birthweight 500–999 g in Victoria. J Paed Child Health 1993;29: 5662.
  • 27
    The Victorian Infant Collaborative Study GroupEconomic outcome for intensive care of infants of birthweight 500–999 g born in Victoria in the post surfactant era. J Paediatr Child Health 1997;33: 202208.
  • 28
    Doyle LW. The cost of neonatal intensive care for tiny infants. In: RennieJM, RobertsonNRC editors. Textbook of Neonatology, 3rd edition. Edinburgh : Churchill Livingstone, 1999: 5560.
  • 29
    Schumacher R, Burchfield D, Vaughan R, et-al. Economic impact of two rescue doses of Exosurf neonatal in ≥1350 gram infants. Pediatr Res 1991;29: 264A, 1570
  • 30
    Mugford M, Piercy J, Chalmers I. Cost implications of different approaches to the prevention of respiratory distress syndrome. Arch Dis Child 1991;66: 757764.
  • 31
    Egberts J. Estimated costs of different treatments of the respiratory distress syndrome in a large cohort of preterm infants of less than 30 weeks gestation. Biol Neonate 1992;61: 5985.
  • 32
    Simpson KN, Lynch SR. Cost savings from the use of antenatal steroids to prevent respiratory distress syndrome and related conditions in premature infants. Am J Obstet Gynecol 1995;173: 316321.
  • 33
    Schwartz R, Luby A, Scanlon J, Kellogg RJ. Effect of surfactant on mortality and resource use in infants weighing 500 to 1500 g. N Engl J Med 1994;330: 14761480.
  • 34
    Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. The Cochrane Library 1999;4: CD001456.
  • 35
    Egberts J. Theoretical changes in neonatal hospitalisation costs after the introduction of porcine-derived lung surfactant (‘Curosurf’). PharmacoEconomics 1995;8: 324342.
  • 36
    Thureen PJ, Reiter PD, Gresores A, Stolpman NM, Kawato K, Hall DM. Once- versus twice-daily gentamicin dosing in neonates ≥34 weeks gestation: cost–effectiveness analyses. Pediatrics 1999;103: 594598.
  • 37
    Roberts TE, Extracorporeal Membrane Oxygenation Economics Working Group Economic evaluation and randomised controlled trial of extracorporeal membrane oxygenation: UK collaborative trial. Br Med J 1998;317: 911915.
  • 38
    Thomas RE, Baker PA. Cost-outcome description of the septic work-up for bacterial infection in neonates in a tertiary care hospital. Int J Technol Assess Healthcare 1995;11: 1125.
  • 39
    Sparnon A, Puri P, O'Donnell B. Cost-benefit analysis of surgery and support of the premature infant. Mod Probl Paediat 1985;23: 183189.
  • 40
    Waitzman NJ, Romano PS, Scheffler RM. Estimates of the economic costs of birth defects. Inquiry 1994;31: 188205.
  • 41
    Metkus AP, Esserman L, Sola A, Harrison MR, Adzick NS. Cost per anomaly: what does a diaphragmatic hernia cost?. J Pediatr Surg 1995;30: 226230.
  • 42
    Miller VL. An analysis of program and family costs of case managed care for technology-dependent infants with bronchopulmonary dysplasia. J Pediatr Nurs 1998;13: 244251.
  • 43
    Calhoun BC, Watson PT. The cost of maternal cocaine abuse: I. Perinatal cost. Obstet Gynecol 1991;78: 731734.
  • 44
    Norton EC, Zarkin GA, Calingaert B, Bradley CJ. The effect of maternal substance abuse on the cost of neonatal care. Inquiry 1996;33: 247257.
  • 45
    Oster G, Delea TE, Colditz GA. The penalties of smoking: low birth weight and increased neonatal care costs. In: RosenbergMJ editors. Smoking and Reproductive Health. Littleton , MA : PSG Publishing Co Inc, 1987: 210214.
  • 46
    Maniscalco WM, Kendig JW, Shapiro DL. Surfactant replacement therapy: impact on hospital charges for premature infants with respiratory distress syndrome. Pediatrics 1989;83: 16.
  • 47
    Tubman TRJ, Halliday HL, Normand C. Cost of surfactant replacement treatment for severe neonatal respiratory distress syndrome: a randomised controlled trial. Br Med J 1990;301: 842845.
  • 48
    Phibbs CS, Phibbs RH, Wakeley A, Schlueter MA, Sniderman S, Tooley WH. Cost–effects of surfactant therapy for neonatal respiratory distress syndrome. J Pediatr 1993;123: 953962.
  • 49
    Backhouse ME, Mauskopf JA, Jones D, et al. Economic outcomes of calfosceril palmitate rescue therapy in infants weighing 1250 g or more with respiratory distress syndrome: results from a randomized trial. Pharmacoeconomics 1994;6: 358369.
  • 50
    Mauskopf JA, Backhouse ME, Jones D, Wold D, Mammel M, Mullett M. Synthetic surfactant for rescue treatment of respiratory distress syndrome in premature infants weighing 700 to 1350 grams: impact on hospital resource use and charges. J Pediatr 1995;126: 94101.
  • 51
    Sell M, Corbett A, Gong A, et al. Economic impact of a single prophylactic dose of Exosurf neonatal in 700–1100 gram infants. Pediatr Res 1991;29: 265A.
  • 52
    Soll RF, Jacobs J, Pashko S, Thomas R. Cost effectiveness of Beractant in the prevention of respiratory distress syndrome. Pharmacoeconomics 1993;4: 278286.
  • 53
    Virtanen M, Kuhlefelt S, Makela-Bengs P, Jarvenpaa AL. Proceedings of the annual meeting of the European Society for Paediatric Research. Edinburgh , September 1993.